- ICH M13B: Step 2b (draft for consultation) Helmut 2025-03-15 10:31
- ICH M13B: EMA Helmut 2025-04-09 09:10
- EMA: GL on quality and equivalence of LALA cutaneous products Helmut 2024-10-03 11:41
- ICH M13A: Changes to Step 2
Helmut 2024-07-31 13:16
- ICH M13A: Changes to Step 2 Helmut 2024-07-31 14:19
- AUCres mittyri 2024-08-05 21:08
- ‘Percentage covered’ Helmut 2024-08-05 22:13
- ICH M13A: Changes to Step 2 BEQool 2024-09-09 05:48
- fixed or mixed effects model Helmut 2024-09-09 07:04
- fixed or mixed effects model BEQool 2024-09-09 10:18
- fixed or mixed effects model Helmut 2024-09-09 11:13
- fixed or mixed effects model BEQool 2024-09-10 07:35
- fixed or mixed effects model Helmut 2024-09-09 11:13
- fixed or mixed effects model Helmut 2024-09-10 08:12
- fixed or mixed effects model BEQool 2024-09-09 10:18
- fixed or mixed effects model Helmut 2024-09-09 07:04
- AUCres mittyri 2024-08-05 21:08
- ICH M13A: Changes to Step 2 Helmut 2024-08-05 12:53
- period within group and formulation mittyri 2024-08-05 20:42
- period within group and formulation Helmut 2024-08-05 22:29
- ICH M13A: Step 4 → 5 Helmut 2024-08-08 11:57
- Formal ICH Procedure Helmut 2024-08-09 09:45
- ICH M13A: Changes to Step 2 Helmut 2024-09-06 08:04
- ICH M13A: Changes to Step 2 Helmut 2024-07-31 14:19
- EMA: ICH M13A coming into effect 25 January 2025 Helmut 2024-09-04 11:30
- Handling and Retention of BA and BE Testing Samples dshah 2024-03-26 17:15
- Handling and Retention of BA and BE Testing Samples Achievwin 2024-04-23 16:16
- EMA: Draft GL for OIPs Helmut 2024-04-19 15:40
- EMA: Draft GL for OIPs Chirag 2024-04-22 04:37
- EMA: Draft GL for OIPs Ohlbe 2024-04-22 14:07
- EMA: Draft GL for OIPs Chirag 2024-04-22 04:37
- Draft FDA guidance on data integrity in BA and BE studies Ohlbe 2024-04-02 14:49
- Handling and Retention of BA and BE Testing Samples suchit_bhavsar 2024-03-27 04:09
- Paper by the IPRP BEWGG Ohlbe 2024-03-22 16:25
- New EMA product specific guidance (PSG) SMA 2024-01-16 09:51
- New EMA product specific guidance (PSG) dshah 2024-01-17 10:12
- ICH M13A (IR BE) Helmut 2022-12-23 09:05
- ICH M13A (IR BE) Rasha_J 2023-01-16 05:27
- ICH M13A (IR BE) Helmut 2023-01-16 09:19
- ICH M13A (IR BE) SMA 2023-01-17 09:30
- ICH M13A (IR BE) dshah 2023-01-17 12:02
- ICH M13A (IR BE) Rasha_J 2023-01-18 09:53
- ICH M13A (IR BE) : FDA web site Ohlbe 2023-02-01 14:14
- Knowledge is power… Helmut 2023-02-09 12:34
- ICH M13A (IR BE): EMA consultation SMA 2023-02-08 09:10
- ICH M13A (IR BE): EMA comments received Helmut 2023-09-18 10:54
- ICH M13A (IR BE) Rasha_J 2023-01-16 05:27
- WHO Draft on BCS-based Biowaivers Helmut 2023-08-29 11:18
- EMA: New product-specific guidances Helmut 2022-04-08 15:17
- How would you implement it? ElMaestro 2022-04-09 11:45
- Confuse a Cat Inc. Helmut 2022-04-09 18:40
- Confuse a Cat Inc. ElMaestro 2022-04-09 21:47
- Confuse a Cat Inc. Ohlbe 2022-04-11 11:29
- Confuse a Cat Inc. Helmut 2022-04-11 13:59
- So many questions, so few answers Helmut 2022-04-11 13:03
- Preliminary simulations Helmut 2022-04-30 14:59
- Preliminary simulations ElMaestro 2022-04-30 19:10
- Preliminary simulations Helmut 2022-05-01 15:56
- Revisions of the PSGLs final Helmut 2023-06-23 13:29
- Revisions of the PSGLs final dshah 2023-06-28 14:43
- EMA: No problems with many sampling time points… Helmut 2023-06-28 15:59
- New simulations & some desultory thoughts Helmut 2023-06-29 11:34
- SCNR. A heretic alternative. Helmut 2023-06-30 11:50
- Revisions of the PSGLs final dshah 2023-06-28 14:43
- Preliminary simulations ElMaestro 2022-04-30 19:10
- Simulated distributions Helmut 2022-05-02 13:43
- Confuse a Cat Inc. Ohlbe 2022-04-11 11:29
- Confuse a Cat Inc. ElMaestro 2022-04-09 21:47
- Confuse a Cat Inc. Helmut 2022-04-09 18:40
- How would you implement it? ElMaestro 2022-04-09 11:45
- ICH E6(R3) draft Guideline reaches Step 2 of the ICH process SMA 2023-05-24 08:37
- Validation of sample size estimations? Helmut 2023-05-29 08:34
- FDA draft guidance on transdermal systems Ohlbe 2023-04-13 08:37